Register Login
Register to leave comments
  • News bot Sept. 3, 2025, 10:02 a.m.

    📋 MONTE ROSA THERAPEUTICS, INC. (GLUE) - financial_results

    Filing Date: 2022-05-11

    Accepted: 2022-05-11 07:38:17

    Event Type: financial_results

    Event Details:

    MONTE ROSA THERAPEUTICS, INC. (GLUE) Reports {period} Financial Results MONTE ROSA THERAPEUTICS, INC. (GLUE) announced its financial results for the period ending 2022-05-11. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 138305
    • “Our first quarter was marked by exciting progress across our pipeline of molecular glue degraders and our proprietary QuEEN™ platform,” said Markus Warmuth, M.D., CEO of Monte Rosa. “Last month, we presented compelling preclinical data underscoring the therapeutic potential of MRT‑2359 as a potent inducer of degradation of GSPT1 in Myc
    • driven solid tumors, and we look forward to submitting our IND for MRT
    • We are also thrilled to work with Professor Bruno Correia and the world experts at EPFL to further realize the potential of our proprietary AI engine to identify next
    • expected in mid-2022
    • expected in 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 3.20K 2.60K $608.00 +23.43%
    Current Assets Property Equipment Net 13.40K 12.32K $1.07K +8.69%
    Current Liabilities Accounts Payable 4.51K 6.56K $-2.05K -31.21%
    Operating Expenses Loss From Operations 24.30K 11.50K $12.80K +111.25%
    Other Income Expense: Total Other Income Expense 370.00 772.00 $-402.00 -52.07%
    Other Income/(Expense), Net: Other Income Expense Net Loss 23.93K 12.28K $11.66K +94.95%
    Prepaid Expenses and: Other Current Assets 3.20K 2.60K $608.00 +23.43%
    Property and: Equipment, Net 13.40K 12.32K $1.07K +8.69%
    Accounts Payable 4.51K 6.56K $-2.05K -31.21%
    Loss from Operations 24.30K 11.50K $12.80K +111.25%
    Net Loss 23.93K 12.28K $11.66K +94.95%

    Structured Data:

    • Company Name: MONTE ROSA THERAPEUTICS, INC.
    • CIK: 0001826457
    • Ticker Symbol: GLUE
    • Period End Date: 2022-05-11
    • Document Type: 8-K

    🔬 Clinical Trial Updates:

    • Data Expected: 2022

    💼 Business Developments:

    • Partnership

Search

News categories